| ²é¿´: 478 | »Ø¸´: 2 | ||
¶»·Ð³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÂÛÎÄ·ÒëÇóÖú
|
|
Repeated intrathecal administration with Adenoviruses expressing CREB-siRNA or miR-132 LNA-AS, respectively, attenuated bone cancer-evoked pain behaviours, reduced the activity of CREB/CRTC1 signalling and down-regulated CREB-target gene NR2B expression in spinal cord. ÕâÒâ˼ÊÇ˵CREB-siRNA »òÕßmiR-132 LNA-AS¶¼¿ÉÒÔµ¼ÖºóÃæµÄ½á¹ûÂ𣿻¹ÊÇǰÕßµ¼ÖÂǰһ¸ö½á¹û£¬ºóÕßµ¼ÖÂÁíÒ»¸ö½á¹û£¿£¿ |
» ²ÂÄãϲ»¶
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ5È˻ظ´
081700£¬311£¬Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
²ÄÁÏÓ뻯¹¤371Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
336²ÄÁÏÓ뻯¹¤085600Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ334Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
331Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ ²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ7È˻ظ´
°¬É˼רÀû
¾èÖú¹ó±ö (ÕýʽдÊÖ)
Éî˼ÊìÂÇ£¬Ö»Ð´ºÃרÀû£¡
- ·ÒëEPI: 24
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 1744
- É¢½ð: 728
- ºì»¨: 17
- Ìû×Ó: 574
- ÔÚÏß: 78.5Сʱ
- ³æºÅ: 5494315
- ×¢²á: 2017-01-17
- רҵ: ¸ß·Ö×Ӻϳɻ¯Ñ§
2Â¥2017-02-18 18:09:58
vcheung098
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 44
- Ó¦Öú: 567 (²©Ê¿)
- ½ð±Ò: 6061.6
- ºì»¨: 119
- Ìû×Ó: 1847
- ÔÚÏß: 369.4Сʱ
- ³æºÅ: 5569286
- ×¢²á: 2017-02-13
- רҵ: Ò©Îﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
¶»·: ½ð±Ò+3, ¡ï¡ï¡ïºÜÓаïÖú 2017-02-20 10:58:03
¶»·: ½ð±Ò+3, ¡ï¡ï¡ïºÜÓаïÖú 2017-02-20 10:58:03
|
Repeated intrathecal administration with Adenoviruses expressing CREB-siRNA or miR-132 LNA-AS, respectively, attenuated bone cancer-evoked pain behaviours, reduced the activity of CREB/CRTC1 signalling and down-regulated CREB-target gene NR2B expression in spinal cord. ÖØ¸´¼¹ÖùÇÊÄÚ¸øÓè±í´ïÁË CREB-siRNA»òÕßmiR-132 LNA-ASµÄÏÙ²¡¶¾µÄÈÎÒâÒ»ÖÖ£¬¼õÈõÁ˹ÇÖ×Áöµ¼ÖµÄÌÛÍ´£¬¼õÉÙÁËCREB/CRT1ÐźÅ;¾¶µÄ»îÐÔ£¬Ïµ÷ÁËCREB°ÐÏò»ùÒòNR2BÔÚ¼¹ËèÖеıí´ï¡£ ¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª ÎÒ¸öÈË´ÓÎÄ×ÖÀí½âÊÇÖ¸±í´ïÁËCREB-siRNA»òÕßmiR-132 LNA-ASµÄÏÙ²¡¶¾¶¼¿ÉÒÔµ¼ÖºóÃæÈý¸öÀàËÆµÄÖÎÁÆÐ§¹û¡£ |
3Â¥2017-02-20 09:33:27














»Ø¸´´ËÂ¥